Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient Transition

NCT04847921 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
11
Enrollment
OTHER
Sponsor class

Stopped Delays in recruitment due to COVID-19 and higher than acceptable loss to followup.

Conditions

Interventions

Sponsor

University of Colorado, Denver